Bayer confirms $62 billion offer to buy Monsanto

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Bayer of Germany said on Monday that it had offered $62 billion in cash to acquire Monsanto in a deal that would combine two of the world’s biggest companies in the businesses of crop seeds and pesticides.

The transaction, if consummated, would create an industry giant whose products include antibiotics, genetically modified crops and pesticides. It would have a combined annual revenue of more than $67 billion.

Bayer said it decided to make details of its proposal public after market speculation and investor inquiries about a potential deal. The companies confirmed last week that Bayer had approached Monsanto about a potential tie-up. Monsanto said then that its board of directors was reviewing the proposal.

The combined company’s seeds business and North American headquarters would be in St. Louis, where Monsanto is based. The company’s pesticides and crop science business would be based in Monheim, Germany.

Read full, original post: Bayer Offers to Buy Monsanto for $62 Billion

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend